Growth Metrics

Armata Pharmaceuticals (ARMP) Non Operating Income (2016 - 2026)

Quarterly results put Non Operating Income at -$106.6 million for Q1 2026, down 6519.34% from a year ago — trailing twelve months through Mar 2026 was -$245.4 million (down 713.86% YoY), and the annual figure for FY2025 was -$137.2 million, down 683.18%.

Armata Pharmaceuticals has reported Non Operating Income over the past 14 years, most recently at -$106.6 million for Q1 2026.

  • Non Operating Income reached -$106.6 million in Q1 2026 per ARMP's latest filing, up from -$110.5 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $20.9 million in Q2 2024 and bottomed at -$110.5 million in Q4 2025.
  • Median Non Operating Income over the past 5 years was $1000.0 (2022), compared with a mean of -$14.6 million.
  • Peak annual rise in Non Operating Income hit 121540.0% in 2023, while the deepest fall reached 314500.0% in 2023.
  • Over 5 years, Non Operating Income stood at $14000.0 in 2022, then crashed by 73442.86% to -$10.3 million in 2023, then soared by 227.96% to $13.1 million in 2024, then crashed by 940.82% to -$110.5 million in 2025, then increased by 3.54% to -$106.6 million in 2026.
  • Business Quant data shows Non Operating Income for ARMP at -$106.6 million in Q1 2026, -$110.5 million in Q4 2025, and -$18.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 444,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 201.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -46.98 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - -106.56 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -106.56 Mn
Dec 31, 2025 -110.48 Mn
Sep 30, 2025 -18.90 Mn
Jun 30, 2025 -9.45 Mn
Mar 31, 2025 1.66 Mn
Dec 31, 2024 13.14 Mn
Sep 30, 2024 4.28 Mn
Jun 30, 2024 20.90 Mn
Mar 31, 2024 -14.79 Mn
Dec 31, 2023 -10.27 Mn
Sep 30, 2023 -20.83 Mn
Jun 30, 2023 6.08 Mn
Mar 31, 2023 -3.14 Mn
Dec 31, 2022 14,000.00
Sep 30, 2022 9,000.00
Jun 30, 2022 5,000.00
Mar 31, 2022 1,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 724,000.00
Jun 30, 2021 2,000.00
Mar 31, 2021 -60,000.00
Dec 31, 2020 -171,000.00
Sep 30, 2020 -146,000.00
Jun 30, 2020 -120,000.00
Mar 31, 2020 -157,000.00
Dec 31, 2019 -210,000.00
Sep 30, 2019 -178,000.00
Jun 30, 2019 959,000.00
Mar 31, 2019 -298,000.00
Dec 31, 2018 1.69 Mn
Sep 30, 2018 -342,000.00
Jun 30, 2018 -324,000.00
Mar 31, 2018 -79,000.00
Dec 31, 2017 13,000.00
Sep 30, 2017 -33,000.00
Jun 30, 2017 1.92 Mn
Mar 31, 2017 113,000.00
Dec 31, 2016 1.81 Mn
Sep 30, 2016 1.03 Mn
Jun 30, 2016 -262,000.00